INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio update as at 31 May 2010
|
Total Net Assets |
£102.7m |
|
NAV per share |
168.2p |
|
Share Price |
138.3p |
|
Total value of unquoted investments |
£22.5m |
|
Total number of portfolio companies |
59 |
|
Cash |
5% |
|
Cash committed and reserved to unquoted investments |
14% |
|
Portfolio companies with < 1 year of cash |
6% |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
5.80 |
|
Amgen |
5.40 |
|
Micromet |
5.08 |
|
Shire |
4.72 |
|
Alexion Pharmaceuticals |
3.84 |
|
Gilead Sciences |
3.60 |
|
Genzyme |
3.39 |
|
EUSA Pharma |
3.14 |
|
Oxagen |
2.83 |
|
EV3 |
2.82 |
|
|
----------- |
|
Total |
40.62 |
|
Geographical Allocation |
% |
|
United States |
75 |
|
Europe |
18 |
|
Cash |
5 |
|
Australia |
2 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted allocation |
% |
|
Quoted |
73 |
|
Unquoted |
22 |
|
Cash |
5 |
|
|
----------- |
|
|
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 JUNE 2010